BU-NOT-SET

CONTACT US
A connected approach to OSD development
  • Drug product
  • Manufacturing
woman in lab
eBook
Choosing a CDMO that can grow with a viral program
  • Biologics
  • Manufacturing
woman in PPE in lab
Insight
Turning oncolytic viruses into manufacturable cancer therapies
  • Biologics
  • Manufacturing
hands in lab
Insight
Science-led OSD reformulation
  • Drug product
  • Manufacturing
woman in lab
Case study
De-risking complex generic OSD development
  • Development
  • Drug product
woman in lab
Case study
Science-led OSD development
  • Development
  • Drug product
lady in lab with PPE
Insight
Advanced deformulation for complex generic development
  • Drug product
  • Manufacturing
three scientists in laboratory
White paper
How to turn development challenges into predictable outcomes
  • Development
  • Drug product
two scientists in laboratory
Webinar
Managing risk as high-potency manufacturing scales
  • Drug product
white powder
Insight
eBook
  • Biologics
Flexibility in gene therapy: Adapting to the unique gene therapy demands
Webinar
  • Biologics
Webinar: An optimised Plasmid DNA platform
Insight
  • Drug substance
  • Industry trends
The future of oral solid dose formulations
Insight
  • Industry trends
Trends and challenges to impact the OSD space in 2024 and beyond
Insight
  • Sustainability
Shaping pharma's carbon-reduced future
Insight
  • Sustainability
Focus on sustainability: Saving water in Bengaluru
Insight
  • Drug product
  • Drug substance
Safe handling of highly potent active pharmaceutical ingredients
White paper
  • Analytical chemistry
Development and validation of ICP-OES for trace element estimation
Webinar
  • Drug product
  • Manufacturing
Blow-fill-seal transforming distribution of biologics and vaccines